Patent application number | Description | Published |
20080247529 | Incoming Call Classification And Disposition - Incoming calls or other messages are automatically categorized and handled based on information gleaned from one or more of the following sources: user location (available contact modes, available contact devices), user-specified preferences, a dialog with the caller, and direct interaction with the callee over a non-telephonic channel. Based on speech recognition of dialog information with the caller and one or more of presence or location information, static rules and direct callee interaction, the disposition of an incoming call is determined by an automated Personal Virtual Assistant. | 10-09-2008 |
20080247530 | Outgoing call classification and disposition - An automated intelligent component (the Personal Virtual Assistant or PVA) is located between a caller and a callee. A caller calls the PVA and directs the PVA to make one or more calls to one or more call recipients. Based on the information obtained from a voice or text dialog with the caller and a combination of other available informational sources, the disposition of an outgoing call is determined and acted upon by PVA. During the call the PVA remains available to take further actions at the request of the call participants. | 10-09-2008 |
20080249778 | Communications Using Different Modalities - Communications between users of different modalities are enabled by a single integrated platform that allows both the input of voice (from a telephone, for example) to be realized as text (such as an interactive text message) and allows the input of text (from the interactive text messaging application, for example) to be realized as voice (on the telephone). Real-time communication may be enabled between any permutation of any number of text devices (desktop, PDA, mobile telephone) and voice devices (mobile telephone, regular telephone, etc.). A call to a text device user may be initiated by a voice device user or vice versa. | 10-09-2008 |
20120170722 | Communications Using Different Modalities - Communications between users of different modalities are enabled by a single integrated platform that allows both the input of voice (from a telephone, for example) to be realized as text (such as an interactive text message) and allows the input of text (from the interactive text messaging application, for example) to be realized as voice (on the telephone). Real-time communication may be enabled between any permutation of any number of text devices (desktop, PDA, mobile telephone) and voice devices (mobile telephone, regular telephone, etc.). A call to a text device user may be initiated by a voice device user or vice versa. | 07-05-2012 |
20150030144 | COMMUNICATIONS USING DIFFERENT MODALITIES - Communications between users of different modalities are enabled by a single integrated platform that allows both the input of voice (from a telephone, for example) to be realized as text (such as an interactive text message) and allows the input of text (from the interactive text messaging application, for example) to be realized as voice (on the telephone). Real-time communication may be enabled between any permutation of any number of text devices (desktop, PDA, mobile telephone) and voice devices (mobile telephone, regular telephone, etc.). A call to a text device user may be initiated by a voice device user or vice versa. | 01-29-2015 |
Patent application number | Description | Published |
20100158893 | SYSTEMS AND METHODS FOR OBTAINING IMMUNOGLOBULIN FROM BLOOD - The present disclosure relates generally to systems for obtaining a pharmaceutically acceptable immunoglobulin from blood of a donor comprising a first conduit configured to convey blood from the donor to a substrate, wherein said blood includes at least one first component and at least one second component, said first component of the blood including immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; and a second conduit configured to convey at least a portion of the second component of the blood from the first conduit to the donor. | 06-24-2010 |
20120230872 | SYSTEMS AND METHODS FOR OBTAINING IMMUNOGLOBULIN FROM BLOOD - The present disclosure relates generally to systems for obtaining a pharmaceutically acceptable immunoglobulin from blood of a donor comprising a first conduit configured to convey blood from the donor to a substrate, wherein said blood includes at least one first component and at least one second component, said first component of the blood including immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; and a second conduit configured to convey at least a portion of the second component of the blood from the first conduit to the donor. | 09-13-2012 |
20130011387 | SYSTEMS AND METHODS FOR OBTAINING IMMUNOGLOBULIN FROM BLOOD - The present disclosure relates generally to systems for obtaining a pharmaceutically acceptable immunoglobulin from blood of a donor comprising a first conduit configured to convey blood from the donor to a substrate, wherein said blood includes at least one first component and at least one second component, said first component of the blood including immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; and a second conduit configured to convey at least a portion of the second component of the blood from the first conduit to the donor. | 01-10-2013 |
20130052188 | SYSTEMS AND METHODS FOR OBTAINING IMMUNOGLOBULIN FROM BLOOD - The present disclosure relates generally to systems for obtaining a pharmaceutically acceptable immunoglobulin from blood of a donor comprising a first conduit configured to convey blood from the donor to a substrate, wherein said blood includes at least one first component and at least one second component, said first component of the blood including immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; and a second conduit configured to convey at least a portion of the second component of the blood from the first conduit to the donor. | 02-28-2013 |
20140242067 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G - The present invention provides, among other aspects, methods and compositions for treating a central nervous system (CNS) disorder by delivering a therapeutically effective amount of a composition of pooled human immunoglobulin G (IgG) to the brain via intranasal administration of the composition directly to the olfactory epithelium of the nasal cavity. In particular, methods and compositions for treating Alzheimer's disease are provided. | 08-28-2014 |
Patent application number | Description | Published |
20080305047 | Chemosensors Based on Quantum Dots and Oxazine Compounds - We identified a mechanism to detect chemical changes with a modified semiconductor nanoparticle (e.g., an oxazine-adsorbed CdSe—ZnS core-shell quantum dot). Our strategy is based on the chemical transformation of chromo-genie ligands adsorbed on the surface of a quantum dot. This activates an energy transfer pathway from the quantum dot to the adsorbed chromogenic ligands, which causes a change (e.g., increase or decrease) in a characteristic of fluorescent emission (e.g., intensity or lifetime). Thus, modified quantum dots acting through this mechanism can efficiently transduce a chemical event or occurrence into a change in optical signal. Our design can be adapted to signal chemical changes by a diversity of target analytes and, thus, it can be used to develop other fluorescent chemosensors based on the unique properties of quantum dots. | 12-11-2008 |
20110095243 | Photochromic compounds based on ring opening and closing of an [1,3]oxazine compound - We have designed a molecular switch based on the photoinduced opening and thermal closing of a [1,3]oxazine ring. A substituted [1,3]oxazine compound described as having a general (i.e., unsubstituted) structure with fused indoline and benzooxazine fragments such that they share a common bond in the [1,3]oxazine compound: (i) the bond connecting positions 1 and 2 of the indoline fragment and (ii) the bond connecting positions 2 and 3 of the benzooxazine fragment. Irradiation by light of suitable wavelength and intensity of this photochromic compound induces cleavage of a [C—O] bond of the [1,3]oxazine ring to form a phenolate chromophore. The photogenerated (e.g., colored) isomer may revert thermally to the starting (e.g., colorless) oxazine. Alternatively, the switch may be between isomers of the compound that absorb at different wavelengths. Reversible coloration of silica or polymeric materials and switching optical signals may involve many cycles of interconversion between different colored states. A colorless/colored state may be maintained by constant irradiation or chemical trapping. | 04-28-2011 |
Patent application number | Description | Published |
20080213625 | Optical Data Storage and Retrieval Based on Fluorescent and Photochromic Components - An optical storage medium | 09-04-2008 |
20090258429 | Colorimetric detection of cyanide with a chromogenic oxazine - A chromogenic oxazine compound for the colorimetric detection of cyanide was designed. Indeed, the [1,3]oxazine ring of our compound opens to form a phenolate chromophore in response to cyanide. The heterocyclic com-pound may be comprised of fused benzooxazine and indoline rings: | 10-15-2009 |
20100112560 | MECHANISM TO SIGNAL RECEPTOR-LIGAND INTERACTIONS WITH LUMINESCENT QUANTUM DOTS - Semiconductor quantum dots are becoming valuable analytical tools for use in biomedical applications. Indeed, their unique properties offer the opportunity to design luminescent probes for imaging and sensing with unprecedented performance. In this context, we have identified operating principles to transduce supramolecular association of complementary receptor-ligand binding pairs into enhancement or suppression in the luminescence of sensitive quantum dots. Thus, complementary receptor-ligand binding pairs can be identified with luminescence measurements relying on our design logic. In fact, we have demonstrated with a representative example that our protocol can be adapted to signal receptor-ligand binding. | 05-06-2010 |
20100249403 | USE OF OXAZINE COMPOUNDS FOR MAKING CHROMOGENIC MATERIALS - Heterocyclic compounds incorporating a [1,3]oxazine ring may be used to make chromogenic materials. These molecules switch from a colorless state to a colored form upon addition of either acid or base. In both instances, the [1,3]oxazine ring opens in response to the pH change forming an indolium cation, after the addition of acid, or a phenolate anion, after the addition of base. Alternatively, the switch may occur in response to a change in electrical current or potential or a change in temperature. Chromophores absorb in the visible region of the electromagnetic spectrum. Hence, their formation translates into the appearance of color. These processes are fully reversible and the original colorless state can be regenerated by switching the pH back to neutral. Thus, these halochromic compounds can be used to develop displays, filters, indicators, lenses, sensors, switches, or windows able to switch their color in response to pH changes. | 09-30-2010 |